SeQuent Scientific Ltd. has enclosed an Investor Presentation on Audited Standalone and Consolidated Financial Results quarter and year ended March 31, 2023 to the BSE and NSE Listing Departments pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.